by Dr. Neville Wilson 30 Jan 2013 Tredaptive was introduced into the European drug market on 3rd July 2008, as a pharmaceutical formulation designed to treat certain forms of mixed dyslipidaemia in patients judged to be at risk of cardiovascular disease. On the basis of…
Month: February 2013
by DR. NEVILLE WILSON. PREAMBLE: Coronary Heart Disease (CHD) remains the leading cause of death in the Western World. Yet, despite the documented decrease in cardiac-related mortality since the late 1960s, the incidence of CHD has not declined in recent years. (1) Data from EUROASPIRE…